Use of Immunosuppressive Therapy for Sarcoidosis
NCT02356445 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2017-08-14
Summary
Retrospective review of the outcome of use of immunosuppressive drugs in treatment of sarcoidosis
Conditions
- Sarcoidosis
Interventions
- OTHER
-
Cytotoxic drug
Observe patients versus treatment type
Sponsors & Collaborators
-
University of Cincinnati
lead OTHER
Principal Investigators
-
Robert P Baughman, MD · University of Cincinnati
Eligibility
- Min Age
- 15 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2018-11-30
- Completion
- 2018-12-31
Countries
- United States
Study Locations
More Related Trials
-
Correlation Between the Microbiome and Type 2 Inflammatory Diseases of CRSwNP
NCT06231004 ·Status: NOT_YET_RECRUITING
-
Medical Therapy Versus Sinus Surgery for Chronic Rhinosinusitis: A Prospective, Multi-institutional Study
NCT01255566 ·Status: COMPLETED
-
Mepolizumab in Nasal Polyposis
NCT01362244 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Nicotine Patches in Patients With Sarcoidosis
NCT00701207 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Performance of the SinuSys Dilation System for Dilation of the Maxillary Sinus Ostium
NCT01623050 ·Status: COMPLETED ·Phase: PHASE1
-
Reversal of Tobacco-Related Sinusitis
NCT00843869 ·Status: COMPLETED
-
Immunologic Aspects of the Pathogenesis of Chronic Sinusitis in Children
NCT00004638 ·Status: COMPLETED ·Phase: NA
-
Biologics in Chronic Rhinosinusitis With Nasal Polyposis
NCT06824649 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Endoscopic Sinus Surgery for Refractory Chronic Sinusitis
NCT02506426 ·Status: UNKNOWN ·Phase: NA
-
Effect of Reslizumab in Chronic Rhinosinusitis
NCT02799446 ·Status: UNKNOWN ·Phase: PHASE3
-
Nasally Delivered Pulmozyme for Sinusitis in Cystic Fibrosis
NCT00416182 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Prednisone onTregs and TH17
NCT01002313 ·Status: COMPLETED
-
The Role of Canine Fossa Trephination in the Severely Diseased Maxillary Sinus
NCT01615536 ·Status: WITHDRAWN ·Phase: NA
-
A Randomized Controlled Trial Evaluating Postoperative Debridement Following Endoscopic Sinus Surgery
NCT02154555 ·Status: COMPLETED ·Phase: NA
-
The Use of Oral N-Acetyl Cysteine for the Treatment of Chronic Sinonasal Symptoms
NCT00866866 ·Status: UNKNOWN ·Phase: PHASE4
-
Preclinical Studies of Omalizumab in Chronic Rhinosinusitis With Nasal Polyposis
NCT04583501 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
CST1-Guided Oral Glucocorticoids Management for CRSwNP
NCT05598411 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Study of Mitomycin C and Nasal Splint to Treat Nasal Synechiae
NCT00966056 ·Status: COMPLETED ·Phase: PHASE2
-
SinuSys Patency of Frontal Recess and Sphenoid Sinus Ostia Study
NCT02463279 ·Status: COMPLETED ·Phase: NA
-
Nasal and Peripheral Blood Biomarkers of CRS Patients Before and After Surgical Intervention
NCT03250429 ·Status: COMPLETED
-
S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps
NCT02291549 ·Status: COMPLETED ·Phase: PHASE3
-
Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis
NCT04430179 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of Inhaled Treatment in Sinusitis
NCT01907204 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Predictive Factors in Chronic Rhinosinusitis With Nasal Polyps
NCT06459622 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Diagnostics of Mycotic Sinusitis in ENT Patients
NCT05955859 ·Status: RECRUITING ·Phase: NA